Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA

NCT04539119 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

B-cell Lymphoma
HBV

Interventions

DRUG: Tenofovir
DRUG: Entecavir

Sponsor

Ruijin Hospital